Stockholders’ Equity (Details) - Schedule of Total Operating Expenses in the Consolidated Statements of Operations - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Schedule of Total Operating Expenses in the Consolidated Statements of Operations [Abstract] | ||
| Research and Development | $ 3,692 | $ 5,586 |
| General and Administrative | 5,715 | 4,661 |
| Total | $ 9,407 | $ 10,247 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of selling, general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|